Matinas BioPharma Files 8-K
Ticker: MTNB · Form: 8-K · Filed: Mar 22, 2024 · CIK: 1582554
| Field | Detail |
|---|---|
| Company | Matinas Biopharma Holdings, Inc. (MTNB) |
| Form Type | 8-K |
| Filed Date | Mar 22, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing, financials
TL;DR
Matinas BioPharma filed an 8-K on 3/22/24 for other events and financials.
AI Summary
Matinas BioPharma Holdings, Inc. filed an 8-K on March 22, 2024, to report other events and financial statements. The filing does not contain specific details about new events or financial figures within the provided text.
Why It Matters
This filing indicates Matinas BioPharma is providing updates to the SEC, which could include significant corporate events or financial reporting.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Matinas BioPharma Holdings, Inc. (company) — Registrant
- March 22, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38022 (identifier) — Commission File Number
- 46-3011414 (identifier) — IRS Employer ID Number
- 1545 Route 206 South, Suite 302 (address) — Principal executive offices
- Bedminster, New Jersey (location) — Principal executive offices location
- 07921 (zip_code) — Principal executive offices zip code
- (908) 484-8805 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Matinas BioPharma?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 22, 2024.
What is the Commission File Number for Matinas BioPharma Holdings, Inc.?
The Commission File Number for Matinas BioPharma Holdings, Inc. is 001-38022.
In which state was Matinas BioPharma Holdings, Inc. incorporated?
Matinas BioPharma Holdings, Inc. was incorporated in Delaware.
What is the business address of Matinas BioPharma Holdings, Inc.?
The business address of Matinas BioPharma Holdings, Inc. is 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921.
Filing Stats: 887 words · 4 min read · ~3 pages · Grade level 14.9 · Accepted 2024-03-22 06:35:18
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-010901.txt ( ) — 235KB
- mtnb-20240322.xsd (EX-101.SCH) — 3KB
- mtnb-20240322_lab.xml (EX-101.LAB) — 33KB
- mtnb-20240322_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MATINAS BIOPHARMA HOLDINGS, INC. Dated: March 22, 2024 By: /s/ Jerome D. Jabbour Name: Jerome D. Jabbour Title: Chief Executive Officer -3-